General Information of Drug (ID: DME8HA3)

Drug Name
BAY 87-2243 Drug Info
Cross-matching ID
PubChem CID
67377767
CAS Number
CAS 1227158-85-1
TTD Drug ID
D0F3RQ

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Cysteine and methionine metabolism 2.14 0.00e+0 43/50 (86%) CBS;PSAT1;PHGDH;...
Glycine, serine and threonine metabolism 2.10 0.00e+0 31/40 (77.5%) CBS;PSAT1;PHGDH;...
Alanine, aspartate and glutamate metabolism 2.08 0.00e+0 27/37 (72.97%) ASNS;ASS1;GOT1;...
Steroid hormone biosynthesis 2.08 0.00e+0 43/61 (70.49%) AKR1C3;HSD17B6;HSD11B1;...
Fructose and mannose metabolism 1.91 4.37e-3 30/33 (90.91%) PFKP;ALDOC;FBP1;...
Glycolysis / Gluconeogenesis 1.90 7.29e-3 56/67 (83.58%) PCK2;PFKP;ALDOC;...
Proximal tubule bicarbonate reclamation 1.89 9.37e-3 21/23 (91.3%) PCK2;CA2;GLUD1;...
Starch and sucrose metabolism 1.89 9.57e-3 25/36 (69.44%) HK2;PYGL;PYGB;...
Galactose metabolism 1.86 1.22e-2 26/31 (83.87%) PFKP;GALE;AKR1B10;...
Arginine biosynthesis 1.86 1.09e-2 17/22 (77.27%) ASS1;GOT1;ASL;...
Mineral absorption 1.85 9.94e-3 48/60 (80%) HMOX1;HEPH;SLC39A4;...
Nicotinate and nicotinamide metabolism 1.85 1.18e-2 25/35 (71.43%) NT5E;SIRT5;NMRK1;...
Retinol metabolism 1.84 1.18e-2 41/68 (60.29%) ALDH1A2;ALDH1A3;DHRS3;...
Arginine and proline metabolism 1.83 1.09e-2 39/50 (78%) PYCR1;GOT1;ARG2;...
Metabolism of xenobiotics by cytochrome P450 1.82 1.17e-2 49/77 (63.64%) GSTT1;GSTA4;ALDH3B1;...
Focal adhesion 1.79 1.57e-2 180/201 (89.55%) VEGFA;FLNB;THBS2;...
Pentose and glucuronate interconversions 1.79 1.54e-2 17/34 (50%) CRYL1;AKR1B10;DCXR;...
ECM-receptor interaction 1.78 1.52e-2 80/88 (90.91%) THBS2;ITGA5;FN1;...
Sulfur metabolism 1.77 1.67e-2 9/10 (90%) MPST;TST;SQOR;...
Pentose phosphate pathway 1.77 1.64e-2 25/30 (83.33%) PFKP;ALDOC;FBP1;...
Rap1 signaling pathway 1.76 1.56e-2 184/210 (87.62%) VEGFA;PDGFA;ID1;...
ErbB signaling pathway 1.76 1.69e-2 79/85 (92.94%) EIF4EBP1;AREG;MYC;...
Pyruvate metabolism 1.75 1.66e-2 41/47 (87.23%) PCK2;ALDH2;PCK1;...
Glyoxylate and dicarboxylate metabolism 1.75 1.59e-2 23/30 (76.67%) SHMT2;PCCB;MMUT;...
Synthesis and degradation of ketone bodies 1.74 1.97e-2 9/10 (90%) HMGCL;BDH2;HMGCS1;...
Valine, leucine and isoleucine degradation 1.72 2.31e-2 42/48 (87.5%) ALDH6A1;PCCB;HMGCL;...
PI3K-Akt signaling pathway 1.72 2.23e-2 317/354 (89.55%) DDIT4;PCK2;VEGFA;...
Glucagon signaling pathway 1.71 2.62e-2 89/107 (83.18%) PCK2;ATF4;PFKP;...
Porphyrin and chlorophyll metabolism 1.70 2.68e-2 23/43 (53.49%) HMOX1;BLVRB;HEPH;...
Amino sugar and nucleotide sugar metabolism 1.67 2.72e-2 38/48 (79.17%) GFPT1;GALE;UAP1;...
RNA transport -1.64 4.76e-2 128/186 (68.82%) SENP2;SUMO1;PRMT5;...
Staphylococcus aureus infection -1.71 1.80e-2 72/95 (75.79%) FPR3;KRT23;FCGR2B;...
mRNA surveillance pathway -1.72 1.62e-2 71/98 (72.45%) PPP2R5E;PAPOLA;NXF3;...
Spinocerebellar ataxia -1.79 7.52e-3 128/143 (89.51%) PSMB6;PSMA4;TBP;...
Viral protein interaction with cytokine and cytokine re... -1.79 8.59e-3 84/100 (84%) CCR2;CXCR3;TNFRSF10C;...
Ribosome biogenesis in eukaryotes -1.80 8.59e-3 52/108 (48.15%) FBL;NHP2;GNL3L;...
Epstein-Barr virus infection -1.80 1.03e-2 189/202 (93.56%) E2F1;PSMD7;ENTPD3;...
Legionellosis -2.01 2.15e-3 51/57 (89.47%) CXCL1;TLR2;RAB1B;...
Systemic lupus erythematosus -2.03 2.86e-3 45/135 (33.33%) TNF;C1R;CD86;...
Spliceosome -2.16 0.00e+0 101/150 (67.33%) RBMXL2;SRSF5;SF3B3;...
Proteasome -2.18 0.00e+0 44/46 (95.65%) PSMB6;PSMA4;PSMA3;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Ewing sarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SK-ES-1 CVCL_0627 Homo sapiens 1.11uM - 10uM 24H
Brain
Glioma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
GI-1 CVCL_1230 Homo sapiens 1.11uM - 10uM 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 24H
MDA-MB-231 CVCL_0062 Homo sapiens 0.01uM - 10uM 24H
MDA-MB-468 CVCL_0419 Homo sapiens 1.11uM - 10uM 24H
Breast ductal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
T-47D CVCL_0553 Homo sapiens 1.11uM - 10uM 24H
Fibrocystic breast disease
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A (Parent) CVCL_0598 Homo sapiens 1.11uM - 10uM 3H, 6H, 12H, 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.01uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
SNU-407 CVCL_5004 Homo sapiens 1.11uM - 10uM 24H
Endometrium
Endometrial adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEC-108 CVCL_2926 Homo sapiens 1.11uM - 10uM 24H
HEC-1-A CVCL_0293 Homo sapiens 1.11uM - 10uM 24H
HEC-251 CVCL_2928 Homo sapiens 1.11uM - 10uM 24H
HEC-265 CVCL_2929 Homo sapiens 1.11uM - 10uM 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CJM CVCL_U797 Homo sapiens 1.11uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.01uM - 10uM 24H
Liver
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
JHH-5 CVCL_1320 Homo sapiens 1.11uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 24H
NCI-H1573 CVCL_1483 Homo sapiens 1.11uM - 10uM 24H
NCI-H838 CVCL_1594 Homo sapiens 1.11uM - 10uM 24H
Lung squamous cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BEN CVCL_1081 Homo sapiens 1.11uM - 10uM 24H
HCC95 CVCL_1276 Homo sapiens 1.11uM - 10uM 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H2110 CVCL_1529 Homo sapiens 1.11uM - 10uM 24H
Muscle
Rhabdomyosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-204 CVCL_0134 Homo sapiens 1.11uM - 10uM 24H
Ovary
Ovarian clear cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
OVTOKO CVCL_3114 Homo sapiens 1.11uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.01uM - 10uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.04uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
22Rv1 CVCL_1045 Homo sapiens 1.11uM - 10uM 24H
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H
IGR-37 CVCL_1303 Homo sapiens 1.11uM - 10uM 24H
Mel-HO CVCL_1402 Homo sapiens 1.11uM - 10uM 24H
SH-4 CVCL_1692 Homo sapiens 1.11uM - 10uM 24H
Umbilical vein
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HUVEC-C CVCL_2959 Homo sapiens 0.01uM - 10uM 24H
Urinary bladder
Bladder carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BC-3C CVCL_1079 Homo sapiens 3.33uM - 10uM 24H
Bladder transitional cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CAL-29 CVCL_1109 Homo sapiens 1.11uM - 10uM 24H